Serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) predict severity of liver disease in chronic hepatitis B

References

• LeeWMHepatitis B virus infectionN Engl J Med1997337173317459392700
   PubMed Web of Science ®Google Scholar
• YilmazBKokluSBuyukbayramHChronic hepatitis B associated with hepatic steatosis, insulin resistance, necroinflammation and fibrosisAfr Health Sci201515371471826957957
   PubMed Web of Science ®Google Scholar
• TangTJKwekkeboomJLamanJDThe role of intrahepatic immune effector cells in inflammatory liver injury and viral control during chronic hepatitis B infectionJ Viral Hepat200310315916712753333
   PubMed Web of Science ®Google Scholar
• ThabetKChanHLPettaSThe MBOAT7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis BHepatology20176561840185028109005
   PubMed Web of Science ®Google Scholar
• BerlangaAGuiu-JuradoEPorrasJAAuguetTMolecular pathways in non-alcoholic fatty liver diseaseClin Exp Gastroenterol2014722123925045276
   PubMedGoogle Scholar
• TerraultNABzowejNHChangKMAASLD guidelines for treatment of chronic hepatitis BHepatology20166326128326566064
   PubMed Web of Science ®Google Scholar
• MohamadnejadMMontazeriGFazlollahiANoninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver diseaseAm J Gastroenterol2006101112537254517029616
   PubMed Web of Science ®Google Scholar
• CadranelJFRufatPDegosFPractices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF)Hepatology200032347748110960438
   PubMed Web of Science ®Google Scholar
• YoonJHGoresGJDeath receptor-mediated apoptosis and the liverJ Hepatol20023740041012175638
   PubMed Web of Science ®Google Scholar
• RossoCCavigliaGPAbateMLCytokeratin 18-aspartate396 apoptotic fragment for fibrosis detection in patients with nonalcoholic fatty liver disease and chronic viral hepatitisDig Liver Dis2016481556126514735
   PubMedGoogle Scholar
• JanssenHLHiguchiHAbdulkarimAGoresGJHepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity by increasing TRAIL-R1/death receptor 4 expressionJ Hepatol200339341442012927928
   PubMed Web of Science ®Google Scholar
• Martin-VilchezSLara-PezziETrapero-MaruganMMoreno-OteroRSanz-CamenoPThe molecular and pathophysiological implications of hepatitis B X antigen in chronic hepatitis B virus infectionRev Med Virol201121531532921755567
   PubMed Web of Science ®Google Scholar
• RaschSAlgulHA clinical perspective on the role of chronic inflammation in gastrointestinal cancerClin Exp Gastroenterol2014726127225143751
   PubMedGoogle Scholar
• HakimMSSpaanMJanssenHLBoonstraAInhibitory receptor molecules in chronic hepatitis B and C infections: novel targets for immunotherapy?Rev Med Virol201424212513824757728
   PubMed Web of Science ®Google Scholar
• ChuPGWeissLMKeratin expression in human tissues and neoplasmsHistopathology200240540343912010363
   PubMed Web of Science ®Google Scholar
• LinderSHavelkaAMUenoTShoshanMCDetermining tumor apoptosis and necrosis in patient serum using cytokeratin 18 as a biomarkerCancer Lett200421411915331168
   PubMed Web of Science ®Google Scholar
• LjumovicDDiamantisIAlegakisAKKouroumalisEADifferential expression of matrix metalloproteinases in viral and non-viral chronic liver diseasesClin Chim Acta20043491–220321115469875
   PubMed Web of Science ®Google Scholar
• YangZHYangSXQinCZChenYXClinical values of elevated serum cytokeratin-18 levels in hepatitis: a meta-analysisHepat Mon2015155e2532826045704
   PubMed Web of Science ®Google Scholar
• ErenFYilmazYKoseSCaspase-cleaved fragments of cytokeratin 18 in patients with chronic hepatitis BClin Chim Acta201041123–242029203220807521
   PubMed Web of Science ®Google Scholar
• LiangJHanTGaoYTJingLMaZThe expression of serum M30 and M65 in chronic hepatitis B patients with non-alcoholic fatty liver diseaseEur Rev Med Pharmacol Sci201519214123412926592838
   PubMed Web of Science ®Google Scholar
• BaeCBKimSSAhnSJCaspase-cleaved fragments of cytokeratin-18 as a marker of inflammatory activity in chronic hepatitis B virus infectionJ Clin Virol201358464164624210327
   PubMed Web of Science ®Google Scholar
• JazwinskiABThompsonAJClarkPJNaggieSTillmannHLPatelKElevated serum CK18 levels in chronic hepatitis C patients are associated with advanced fibrosis but not steatosisJ Viral Hepat201219427828222404726
   PubMed Web of Science ®Google Scholar
• CusiKChangZHarrisonSLimited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with nonalcoholic fatty liver diseaseJ Hepatol201460116717423973932
   PubMed Web of Science ®Google Scholar
• SumerSAktug DemirNKolgelierSThe clinical significance of serum apoptotic cytokeratin 18 neoepitope M30 (CK-18 M30) and matrix metalloproteinase 2 (MMP-2) levels in chronic hepatitis B patients with cirrhosisHepat Mon2013136e1010624032040
   PubMed Web of Science ®Google Scholar
• BruntEMJanneyCGDi BisceglieAMNeuschwander-TetriBABaconBRNonalcoholic steatohepatitis: a proposal for grading and staging the histological lesionsAm J Gastroenterol19999492467247410484010
   PubMed Web of Science ®Google Scholar
• IshakKBaptistaABianchiLHistological grading and staging of chronic hepatitisJ Hepatol19952266966997560864
   PubMed Web of Science ®Google Scholar
• BedossaPPoynardTAn algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study GroupHepatology19962422892938690394
   PubMed Web of Science ®Google Scholar
• BrouwerWPvan der MeerAJBoonstraAThe impact of PNPLA3 (rs738409 C>G) polymorphisms on liver histology and long-term clinical outcome in chronic hepatitis B patientsLiver Int201535243844725284145
   PubMed Web of Science ®Google Scholar
• YilmazYDolarEUlukayaEElevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis CMed Sci Monit2009154CR189CR19319333204
   PubMed Web of Science ®Google Scholar
• BraatHvan den BrandeJvan TolEHommesDPeppelenboschMvan DeventerSLactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell functionAm J Clin Nutr20048061618162515585777
   PubMed Web of Science ®Google Scholar
• RobinXTurckNHainardApROC: an open-source package for R and S+ to analyze and compare ROC curvesBMC Bioinformatics2011127721414208
   PubMed Web of Science ®Google Scholar
• YilmazYSystematic review: caspase-cleaved fragments of cytokeratin 18 – the promises and challenges of a biomarker for chronic liver diseaseAliment Pharmacol Ther20093011–121103110919769633
   PubMed Web of Science ®Google Scholar
• KaiserAMSalujaAKLuLYamanakaKYamaguchiYSteerMLEffects of cycloheximide on pancreatic endonuclease activity, apoptosis, and severity of acute pancreatitisAm J Physiol19962713 pt 1C982C9938843729
   PubMed Web of Science ®Google Scholar
• VerveerCZondervanPEten KateFJHansenBEJanssenHLde KnegtRJEvaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and CLiver Int201232462262822098684
   PubMed Web of Science ®Google Scholar